Home  Issuers' Corner  Press Releases
CLOSE

Press Releases

company search
all press releases
all Pharmstandard press releases

Pharmstandard

June 28, 2013

Pharmstandard OJSC announces the acquisition of a 41.93% stake in "Biolek" PJSC (Ukraine)

Moscow, May 28, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) announces the acquisition of 41.93% stake in "Biolek" PJSC (Ukraine) to reach 96.93% participation. Main objectives are to increase production capacities and to strengthen positions on a Ukrainian pharmaceutical market.

The deal was financed by Pharmstandard's own funds.

"Biolek" PJSC, a TOP-20 Ukrainian pharmaceutical company, is the producer of immunobiological products, vaccines, serums, diagnostics, culture mediums, blood products, hormonal, antiviral, antibacterial and enzymatic products.

Biolek's sales comprised USD21m in 2012.

Pharmstandard OJSC plans to modernize facilities and expand product portfolio on "Biolek" PJSC (Ukraine).

Irina Bakhturina        
Investor Relations
OJSC Pharmstandard
+7 495 970 00 30 ext.2824
www.pharmstd.com

 

 

 

Search by industry

Agriculture, Foresty and Fishing | Chemicals | Engineering | Ferrous Metals | Financial, Insurance & Real Estate | Food & Kindred Products | General Construction | Information Technology | Media & Publishing | Non-Ferrous Metals | Oil & Gas | Pharmaceuticals | Power Industry | Precious Metals and Diamonds | Telecommunications | Transportation | Wholesale & Retail Trade

Search by alpha index

A B C D F G H I K L M N O P R S T U V W X Z



Site Map
© RUSTOCKS.com
Privacy Statement | Disclaimer